The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis
Open accessAbstract
PURPOSE: Tumor-associated neutrophils (TAN) have been reported in a variety of malignancies. We conducted an up-to-date meta-analysis to evaluate the prognostic role of TAN in cancer. METHOD: Pubmed, Embase and web of science databases were searched for studies published up to April 2013. Pooled hazard ratios (HRs) and their corresponding 95% confidence intervals (CIs) were calculated. The impact of neutrophils localization and primary antibody were also assessed. RESULTS: A total of 3946 patients with various solid tumors from 20 studies were included. High density of intratumoral neutrophils were independently associated with unfavorable survival; the pooled HRs were 1.68 (95%CI: 1.36-2.07, I2 = 55.8%, p<0.001) for recurrence-free survival (RFS)/disease-free survival (DFS), 3.36 (95%CI: 2.08-5.42, I2 = 0%, p<0.001) for cancer-specific survival (CSS) and 1.66 (95%CI: 1.37-2.01, I2 = 70.5%, p<0.001) for overall survival (OS). Peritumoral and stromal neutrophils were not statistically significantly associated with survival. When grouped by primary antibody, the pooled HRs were 1.80 (95%CI: 1.47-2.22, I2 = 67.7%, p<0.001) for CD66b, and 1.44 (95%CI: 0.90-2.30, I2 = 45.9%, p = 0.125) for CD15, suggesting that CD66b positive TAN might have a better prognostic value than CD15. CONCLUSION: High levels of intratumoral neutrophils are associated with unfavorable recurrence-free, cancer-specific and overall survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Practical methods for incorporating summary time-to-event data into meta-analysis.
Tierney, J. F., Stewart, L. A., Ghersi, D., Burdett, S., & Sydes, M. R. (2007) · Trials · doi:10.1186/1745-6215-8-16 · Cited by 6,208
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
ELAM-1 Mediates Cell Adhesion by Recognition of a Carbohydrate Ligand, Sialyl-Le x
Phillips, M. L., Nudelman, E., Gaeta, F. C. A., Perez, M., Singhal, A. K., Hakomori, S.-I., & Paulson, J. C. (1990) · Science · doi:10.1126/science.1701274 · Cited by 1,306
Zhang, Q.-W., Liu, L., Gong, C.-Y., Shi, H.-S., Zeng, Y.-H., Wang, X.-Z., Zhao, Y.-W., & Wei, Y.-Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050946 · Cited by 1,039
Language bias in randomised controlled trials published in English and German
Egger, M., Zellweger-Zähner, T., Schneider, M., Junker, C., Lengeler, C., & Antes, G. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02419-7 · Cited by 1,028
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Ino, Y., Yamazaki-Itoh, R., Shimada, K., Iwasaki, M., Kosuge, T., Kanai, Y., & Hiraoka, N. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.32 · Cited by 849
Tumor associated macrophages and neutrophils in cancer
Galdiero, M. R., Bonavita, E., Barajon, I., Garlanda, C., Mantovani, A., & Jaillon, S. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.06.003 · Cited by 597
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
Chlebowski, R. T., Anderson, G. L., Gass, M., Lane, D. S., Aragaki, A. K., Kuller, L. H., Manson, J. E., Stefanick, M. L., Ockene, J., Sarto, G. E., et al. (2010) · JAMA · doi:10.1001/jama.2010.1500 · Cited by 567
Kuang, D.-M., Zhao, Q., Wu, Y., Peng, C., Wang, J., Xu, Z., Yin, X.-Y., & Zheng, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.041 · Cited by 499
Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., & von der Maase, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9498 · Cited by 461
Self-citationZhou, S.-L., Dai, Z., Zhou, Z.-J., Wang, X.-Y., Yang, G.-H., Wang, Z., Huang, X.-W., Fan, J., & Zhou, J. (2012) · Hepatology · doi:10.1002/hep.25907 · Cited by 356
Rao, H.-L., Chen, J.-W., Li, M., Xiao, Y.-B., Fu, J., Zeng, Y.-X., Cai, M.-Y., & Xie, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030806 · Cited by 327
Dumitru, C. A., Lang, S., & Brandau, S. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.005 · Cited by 303
Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma
Donskov, F., & von der Maase, H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9594 · Cited by 299
Self-citationImmunomonitoring and prognostic relevance of neutrophils in clinical trials
Donskov, F. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.001 · Cited by 293
Self-citationJensen, T. O., Schmidt, H., Møller, H. J., Donskov, F., Høyer, M., Sjoegren, P., Christensen, I. J., & Steiniche, T. (2012) · Cancer · doi:10.1002/cncr.26511 · Cited by 281
Self-citationTrellakis, S., Bruderek, K., Dumitru, C. A., Gholaman, H., Gu, X., Bankfalvi, A., Scherag, A., Hütte, J., Dominas, N., Lehnerdt, G. F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25892 · Cited by 281
Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
Li, Y.-W., Qiu, S.-J., Fan, J., Zhou, J., Gao, Q., Xiao, Y.-S., & Xu, Y.-F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.044 · Cited by 268
Caruso, R. A., Bellocco, R., Pagano, M., Bertoli, G., Rigoli, L., & Inferrera, C. (2002) · Modern Pathology · doi:10.1097/01.mp.0000020391.98998.6b · Cited by 194
On the cytokines produced by human neutrophils in tumors
Tecchio, C., Scapini, P., Pizzolo, G., & Cassatella, M. A. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.004 · Cited by 188
Ilie, M., Hofman, V., Ortholan, C., Bonnetaud, C., Coëlle, C., Mouroux, J., & Hofman, P. (2012) · Cancer · doi:10.1002/cncr.26456 · Cited by 179
Gao, Q., Zhao, Y.-J., Wang, X.-Y., Qiu, S.-J., Shi, Y.-H., Sun, J., Yi, Y., Shi, J.-Y., Shi, G.-M., Ding, Z.-B., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4032 · Cited by 174
Chen, L., Wang, L., Tsang, N., Ojcius, D. M., Chen, C., OuYang, C., Hsueh, C., Liang, Y., Chang, K., Chen, C., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201569 · Cited by 173
Brandau, S., Moses, K., & Lang, S. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.007 · Cited by 159
Neutrophil-mediated tumour angiogenesis: Subversion of immune responses to promote tumour growth
Tazzyman, S. J., Niaz, H. A., & Murdoch, C. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.003 · Cited by 153
The Prognostic Value of Tumor-Infiltrating Neutrophils in Gastric Adenocarcinoma after Resection
Zhao, J., Pan, K., Wang, W. T., Chen, J.-G., Wu, Y., Lv, L. L., Li, J. J., Chen, Y.-B., Wang, D., Pan, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033655 · Cited by 149
CD66a, CD66b, CD66c, and CD66d each Independently stimulate neutrophils
Skubitz, K. M., Campbell, K. D., & Skubitz, A. P. N. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.1.106 · Cited by 135
Carus, A., Ladekarl, M. B., Hager, H., Nedergaard, B. S., & Donskov, F. N. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.167 · Cited by 133
Self-citationCarus, A., Ladekarl, M. B., Hager, H., Pilegaard, H. K., Nielsen, P. S., & Donskov, F. N. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.03.003 · Cited by 128
Self-citationGu, F., Gao, Q., Shi, G., Zhang, X., Wang, J., Jiang, J.-H., Wang, X., Shi, Y.-H., Ding, Z., Fan, J., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2268-8 · Cited by 115
Richards, C. H., Flegg, K. M., Roxburgh, C. S. D., Going, J. J., Mohammed, Z., Horgan, P. G., & McMillan, D. C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.211 · Cited by 86
Predictors and mortality associated with treatment default in pulmonary tuberculosis.
Kliiman, K., & Altraja, A. (2010) · PubMed · Cited by 85
AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma
Dumitru, C. A., Bánkfalvi, Á., Gu, X., Zeidler, R., Brandau, S., & Lang, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056420 · Cited by 62
The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development
Jang, T. J., Park, J. B., & Lee, J. I. (2013) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2013.47.4.340 · Cited by 57
Donskov, F. N., Bennedsgaard, K. M., Hokland, M., Marcussen, N., Fisker, R. V., Madsen, H. H. T., Fode, K., & von der Maase, H. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0525-9 · Cited by 42
Self-citationNeutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma
Dumitru, C. A., Bánkfalvi, Á., Gu, X., Eberhardt, W., Zeidler, R., Lang, S., & Brandau, S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00033 · Cited by 30
Nedergaard, B. S., Nielsen, K., Nyengaard, J. R., & Ladekarl, M. B. (2007) · Apmis · doi:10.1111/j.1600-0643.2007.00655.x · Cited by 12
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities
Ho, W. J., Jaffee, E. M., & Zheng, L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0363-5 · Cited by 1,287
Tumour-associated neutrophils in patients with cancer
Shaul, M. E., & Fridlender, Z. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0222-4 · Cited by 1,023
Teijeira, Á., Garasa, S., Gato, M., Alfaro, C., Migueliz, I., Cirella, A., de Andrea, C., Ochoa, M. C., Otano, I., Etxeberria, I., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.001 · Cited by 788
Metadata
- Authors
- Shen, M., Hu, P., Donskov, F., Wang, G., Liu, Q., & Du, J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-06-06
- Volume
- 9
- Issue
- 6
- Pages
- e98259
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1980029123
- Cited by
- 347
- References
- 42
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.